I do not know what their game is, but I have some ideas. It is possible it is a drug or concoction looking for a disease.
The CEO said the trial with UC failed to meet it's endpoint, but that additional doses will continue up to 16 weeks, I believe. At that time the PPS slumped to about 1.08. I understand that the trial was a failure from the start, but safety was a key milestone and touted as such by the CEO. When the stock finally recovered somewhat, there was massive selling on managements part. Form 4's all over the place, while us investors are strung along on a 16 week ride waiting for the results of additional doses. No such cigar. An outright lie. This bought time for what management there is at Athersys to sell and sell hard.It is my opinion that Multistem will be quite successful, but I question your ethics in manipulating the share price, on a wild fucking story giving
1. Management time to unload.
2. Extract an M&A deal with a manipulated share price to the liking of any suitor,leaving us shareholders out in the cold. so that possibly a management buyout can occur backed by another company at an unfair price to your retail and institutional shareholders. Also, there is a potential to go private at this low PPS, giving employees large raises. While MBOs are viewed as good investment opportunities by hedge funds and large financiers, who usually encourage the company to go private (at a large loss to the retail sector) so that it can streamline operations and improve profitability away from the public eye, and then take it public at a much higher valuation down the road. While private equity funds may also participate in MBOs, their preference may be for MBIs, where the companies are run by managers they know rather than the incumbent management team.
Look Athersys has to be honest. What is the UC trial final result?
What are your plans?
